000			03303nam a22004695i 4500
001			978-3-540-73277-8
003			DE-He213
005			20161121230848.0
007			cr nn 008mamaa
008			100301s2008 gw | s |||| 0|eng d
020			_a9783540732778 _9978-3-540-73277-8
024	7		_a10.1007/978-3-540-73277-8 _2doi
050		4	_aRB45
072		7	_aMJF _2bicssc
072		7	_aMED038000 _2bisacsh
082	0	4	_a616.15 _223
245	1	0	_aConcise Manual of Hematology and Oncology _h[electronic resource] / _cedited by Dietmar P. Berger, Monika Engelhardt, Hartmut Henß, Roland Mertelsmann.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2008.
300			_aXXI, 1002 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aPrinciples of Medical Oncology -- Special Diagnostics -- Pharmacology and Pharmacotherapy -- Supportive Treatment -- Particular Treatment Procedures -- Hematology and Hemostasis -- Hematological Neoplasia -- Medical Oncology -- Hematological and Oncological Emergencies -- Standard Operating Procedures (SOP) -- Standardized Treatment Protocols.
520			_aHow Do We Treat? Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Pra- tice.” Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.
650		0	_aMedicine.
650		0	_aHematology.
650		0	_aOncology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aHematology.
650	2	4	_aOncology.
700	1		_aBerger, Dietmar P. _eeditor.
700	1		_aEngelhardt, Monika. _eeditor.
700	1		_aHenß, Hartmut. _eeditor.
700	1		_aMertelsmann, Roland. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783540732761
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-540-73277-8
912			_aZDB-2-SME
950			_aMedicine (Springer-11650)
999			_c505056 _d505056